Stock Chart

BRNS

$0.74 -2.49%
Score: 32.1 EXTENDED
Pro
Screener
Vol: 5.98x (vs SPY: 10.2x | vs QQQ: 7.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Sep 08, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BRNS - Barinthus Biotherapeutics plc American Depositary Shares

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Key Statistics

Market Cap $31M

This BRNS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BRNS's price movements with trendlines, gamma walls, and key support/resistance levels.